GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (WBO:MDT) » Definitions » Debt-to-Equity

Medtronic (WBO:MDT) Debt-to-Equity

: 0.49 (As of Jan. 2024)
View and export this data going back to 2021. Start your Free Trial

Medtronic's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €945 Mil. Medtronic's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €22,172 Mil. Medtronic's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €47,545 Mil. Medtronic's debt to equity for the quarter that ended in Jan. 2024 was 0.49.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medtronic's Debt-to-Equity or its related term are showing as below:

WBO:MDT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.44   Med: 0.53   Max: 1.43
Current: 0.49

During the past 13 years, the highest Debt-to-Equity Ratio of Medtronic was 1.43. The lowest was 0.44. And the median was 0.53.

WBO:MDT's Debt-to-Equity is ranked worse than
72.09% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs WBO:MDT: 0.49

Medtronic Debt-to-Equity Historical Data

The historical data trend for Medtronic's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-Equity
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.49 0.51 0.46 0.47

Medtronic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.47 0.49 0.49 0.49

Competitive Comparison

For the Medical Devices subindustry, Medtronic's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medtronic's Debt-to-Equity falls into.



Medtronic Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medtronic's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Medtronic's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medtronic  (WBO:MDT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Medtronic Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medtronic's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic (WBO:MDT) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (WBO:MDT) Headlines

From GuruFocus

Q2 2022 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2024 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Medtronic PLC ESG Investor Meeting Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024